European Union Debates Further Patent Protections
The European Commission has presented a proposed regulation to extend patent protections across the Union.
Intellectual Property
-
Read more: European Union Debates Further Patent Protections -
Read more: Is Messenger RNA Patent-Eligible? Is Messenger RNA Patent-Eligible?
Amid ongoing patent disputes over the mRNA platform, a significant scientific question remains unanswered: whether mRNA itself even is patent eligible.
-
Read more: The European Commission’s New Compulsory Licensing Proposal: A Step Forward? The European Commission’s New Compulsory Licensing Proposal: A Step Forward?
The EU’s effort to establish a Union compulsory license is a step toward harmonizing patent law and creating a more effective single market.
-
Read more: Public Health Product Hops Public Health Product Hops
Are there circumstances for which allowing a product hop resulted in a net benefit to society that exceeded the excess costs associated with the new product?
-
Read more: Monthly Round-Up of What to Read on Pharma Law and Policy Monthly Round-Up of What to Read on Pharma Law and Policy
Interesting empirical studies, policy analyses, and editorials on health law and policy issues from March 2023.
-
Read more: Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection Unlocking the mRNA Platform Technology: Walking the Talk with Investment Protection
Recent articles emphasize the need to reform intellectual property protections for government-funded inventions of public health significance.
-
Read more: Should Brain Scans Be Used As Evidence in Trademark Litigation? Should Brain Scans Be Used As Evidence in Trademark Litigation?
A neuroscientifically informed consumer confusion test for trademark infringement holds promise for reducing biases and manipulations.
-
Read more: How Soon Could President Biden Enable Generic Competition to Xtandi? Very Quickly, If There Is the Will. How Soon Could President Biden Enable Generic Competition to Xtandi? Very Quickly, If There Is the Will.
The Biden Administration could take a number of legal measures to ensure the timely entrance of a generic competitor to Xtandi.
-
Read more: FTC’s Proposed Non-Compete Rule: A Step in the Right Direction for Health Care and Biotechnology FTC’s Proposed Non-Compete Rule: A Step in the Right Direction for Health Care and Biotechnology
In January, the FTC released a draft rule that would ban non-compete clauses. This may promote competition and innovation in biotechnology.
-
Read more: Visualizing the Growing Intersection of Life Sciences and Computing Patents in the US from 1976-2021 Visualizing the Growing Intersection of Life Sciences and Computing Patents in the US from 1976-2021
Mapping the growth of U.S. innovation in the life sciences and computing fields from 1976-2021 through publicly available patent data.
